Pliant Therapeutics (PLRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.90, -7.42% vs the prior close of $0.97.
- Volume 582.31K shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PLRX slides 7.4% to $0.90. Closed at $0.90, -7.42% vs the prior close of $0.97. Day range $0.89–$0.99, opened at $0.97.
PLRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PLRX slides 7.4% to $0.90
- Closed at $0.90, -7.42% vs the prior close of $0.97. Day range $0.89–$0.99, opened at $0.97.
- Volume was 582.31K shares, 1.4x its 50-day average of 428.35K.
- Price is -17.2% vs its 50-day average ($1.09) and -23.9% vs its 200-day average ($1.18).
- 52-week range $0.88–$1.95; today's close sits at 1% of that range, 53.9% below the 52-week high.
Oct 15, 2026 — PLRX jumps 10.0% to $0.97
- Closed at $0.97, +9.95% vs the prior close of $0.88. Day range $0.90–$0.97, opened at $0.90.
- Volume was 481.30K shares, 1.1x its 50-day average of 421.78K.
- Price is -10.8% vs its 50-day average ($1.09) and -17.9% vs its 200-day average ($1.18).
- 52-week range $0.88–$1.95; today's close sits at 8% of that range, 50.2% below the 52-week high.
Oct 14, 2026 — PLRX slides 8.7% to $0.88, a 52-week low on 2.4x normal volume
- Closed at $0.88, -8.68% vs the prior close of $0.97. Day range $0.88–$0.98, opened at $0.96.
- Volume was 988.60K shares, 2.4x its 50-day average of 407.20K — unusually heavy trading.
- Price is -19.0% vs its 50-day average ($1.09) and -25.4% vs its 200-day average ($1.19).
- 52-week range $0.88–$1.95; today's close sits at 0% of that range, 54.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — PLRX dips 1.8% to $0.97, a 52-week low
- Closed at $0.97, -1.83% vs the prior close of $0.99. Day range $0.96–$1.00, opened at $0.98.
- Volume was 284.60K shares, 0.7x its 50-day average of 404.74K.
- Price is -11.5% vs its 50-day average ($1.09) and -18.5% vs its 200-day average ($1.19).
- 52-week range $0.96–$1.95; today's close sits at 1% of that range, 50.4% below the 52-week high.
Oct 12, 2026 — PLRX slides 3.3% to $0.99, a 52-week low
- Closed at $0.99, -3.33% vs the prior close of $1.02. Day range $0.99–$1.03, opened at $1.03.
- Volume was 272.20K shares, 0.7x its 50-day average of 405.98K.
- Price is -10.0% vs its 50-day average ($1.10) and -17.0% vs its 200-day average ($1.19).
- 52-week range $0.97–$1.95; today's close sits at 2% of that range, 49.4% below the 52-week high.
Oct 9, 2026 — PLRX rises 2.0% to $1.02
- Closed at $1.02, +2.00% vs the prior close of $1.00. Day range $0.99–$1.03, opened at $0.99.
- Volume was 288.50K shares, 0.7x its 50-day average of 403.66K.
- Price is -7.0% vs its 50-day average ($1.10) and -14.2% vs its 200-day average ($1.19).
- 52-week range $0.97–$1.95; today's close sits at 5% of that range, 47.7% below the 52-week high.
Oct 8, 2026 — PLRX rises 1.0% to $1.00
- Closed at $1.00, +1.01% vs the prior close of $0.99. Day range $0.98–$1.03, opened at $1.00.
- Volume was 568.00K shares, 1.4x its 50-day average of 396.87K.
- Price is -8.9% vs its 50-day average ($1.10) and -16.0% vs its 200-day average ($1.19).
- 52-week range $0.97–$1.95; today's close sits at 3% of that range, 48.7% below the 52-week high.
Oct 7, 2026 — PLRX slides 3.9% to $0.99, a 52-week low on 1.9x normal volume
- Closed at $0.99, -3.88% vs the prior close of $1.03. Day range $0.97–$1.03, opened at $1.03.
- Volume was 756.50K shares, 1.9x its 50-day average of 388.92K — unusually heavy trading.
- Price is -9.9% vs its 50-day average ($1.10) and -16.9% vs its 200-day average ($1.19).
- 52-week range $0.97–$1.95; today's close sits at 2% of that range, 49.2% below the 52-week high.
- That makes 9 straight losses.
Oct 6, 2026 — PLRX ends flat (+0.0%) to $1.03, 8 down days in a row
- Closed at $1.03, +0.00% vs the prior close of $1.03. Day range $1.01–$1.04, opened at $1.04.
- Volume was 276.40K shares, 0.7x its 50-day average of 387.56K.
- Price is -6.4% vs its 50-day average ($1.10) and -13.6% vs its 200-day average ($1.19).
- 52-week range $1.01–$1.95; today's close sits at 2% of that range, 47.2% below the 52-week high.
- That makes 8 straight losses.
Oct 5, 2026 — PLRX dips 0.5% to $1.03, a 1-month low, 7 down days in a row
- Closed at $1.03, -0.48% vs the prior close of $1.03. Day range $1.02–$1.05, opened at $1.04.
- Volume was 295.60K shares, 0.8x its 50-day average of 387.80K.
- Price is -6.4% vs its 50-day average ($1.10) and -13.7% vs its 200-day average ($1.19).
- 52-week range $1.02–$1.95; today's close sits at 1% of that range, 47.2% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — PLRX dips 1.4% to $1.03, a 1-month low, 6 down days in a row
- Closed at $1.03, -1.43% vs the prior close of $1.05. Day range $1.03–$1.07, opened at $1.06.
- Volume was 402.80K shares, 1.0x its 50-day average of 387.60K.
- Price is -6.1% vs its 50-day average ($1.10) and -13.4% vs its 200-day average ($1.19).
- 52-week range $1.02–$1.95; today's close sits at 2% of that range, 46.9% below the 52-week high.
- That makes 6 straight losses.
PLRX latest news & SEC filings
Every SEC filing by or about PLRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$22.37M (prior year -$43.30M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.36 (prior year -$0.71) (loss narrowed vs Jun 30, 2025)
Jul 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade PLRX
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 11, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.67% (largest 10.0%).
- Liquidity: about 397.76K shares (≈$357.94K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.90 vs a range of $0.88–$1.95 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 16 sales; latest: Minnie Kuo sold 6,917 shares on Jan 20, 2026.
- Latest filings: 8-K Aug 11, 2026; 10-Q Aug 11, 2026; 8-K Jul 13, 2026.
- Share count: 61.92M shares outstanding (Aug 7, 2026), +0.9% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PLRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.97 | 0.99 | 0.89 | 0.90 | 582.31K |
| Oct 15, 2026 | 0.90 | 0.97 | 0.90 | 0.97 | 481.30K |
| Oct 14, 2026 | 0.96 | 0.98 | 0.88 | 0.88 | 988.60K |
| Oct 13, 2026 | 0.98 | 1.00 | 0.96 | 0.97 | 284.60K |
| Oct 12, 2026 | 1.03 | 1.03 | 0.99 | 0.99 | 272.20K |
| Oct 9, 2026 | 0.99 | 1.03 | 0.99 | 1.02 | 288.50K |
| Oct 8, 2026 | 1.00 | 1.03 | 0.98 | 1.00 | 568.00K |
| Oct 7, 2026 | 1.03 | 1.03 | 0.97 | 0.99 | 756.50K |
| Oct 6, 2026 | 1.04 | 1.04 | 1.01 | 1.03 | 276.40K |
| Oct 5, 2026 | 1.04 | 1.05 | 1.02 | 1.03 | 295.60K |
| Oct 2, 2026 | 1.06 | 1.07 | 1.03 | 1.03 | 402.80K |
| Oct 1, 2026 | 1.10 | 1.10 | 1.05 | 1.05 | 379.60K |
| Sep 30, 2026 | 1.09 | 1.09 | 1.07 | 1.08 | 238.70K |
| Sep 29, 2026 | 1.09 | 1.12 | 1.08 | 1.08 | 214.50K |
| Sep 28, 2026 | 1.08 | 1.10 | 1.07 | 1.08 | 349.10K |
| Sep 25, 2026 | 1.14 | 1.14 | 1.08 | 1.08 | 450.20K |
| Sep 24, 2026 | 1.13 | 1.15 | 1.11 | 1.14 | 398.00K |
| Sep 23, 2026 | 1.14 | 1.14 | 1.10 | 1.12 | 254.30K |
| Sep 22, 2026 | 1.12 | 1.15 | 1.11 | 1.14 | 324.70K |
| Sep 21, 2026 | 1.12 | 1.13 | 1.11 | 1.11 | 149.30K |
About Pliant Therapeutics
Pliant Therapeutics (PLRX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1746473.
PLRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Flavia Borellini | Director | Jul 13, 2026 |
| Gayle A Crowell | Director | Jun 12, 2026 |
| Darren S Cline | Director | Jun 12, 2026 |
| Bernard Coulie | President and CEO | Apr 17, 2026 |
| John T Curnutte | Director | Jun 12, 2026 |
| Hoyoung Huh | Director | Jun 12, 2026 |
| Robert Iannone | Director | Jul 13, 2026 |
| Steve E. Krognes | Director | Jun 12, 2026 |
| Thomas A Mccourt | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lily Cheung | Chief Human Resource Officer | Apr 17, 2026 |
| Bernard Coulie | President and CEO | Apr 17, 2026 |
| Keith Lamont Cummings | Chief Financial Officer | Apr 17, 2026 |
| Minnie Kuo | Chief Operating Officer | Apr 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jan 20, 2026 | Minnie Kuo | Sale | 6,917 | $1.28 |
| Jan 20, 2026 | Minnie Kuo | Sale | 6,917 | $1.28 |
| Jan 20, 2026 | Minnie Kuo | Sale | 6,917 | $1.28 |
| Jan 20, 2026 | Minnie Kuo | Sale | 6,917 | $1.28 |
| Jan 20, 2026 | Keith Lamont Cummings | Sale | 24,002 | $1.28 |
| Jan 20, 2026 | Keith Lamont Cummings | Sale | 24,002 | $1.28 |
| Jan 20, 2026 | Keith Lamont Cummings | Sale | 24,002 | $1.28 |
| Jan 20, 2026 | Keith Lamont Cummings | Sale | 24,002 | $1.28 |
| Jan 20, 2026 | Lily Cheung | Sale | 7,534 | $1.28 |
| Jan 20, 2026 | Lily Cheung | Sale | 7,534 | $1.28 |
| Jan 20, 2026 | Lily Cheung | Sale | 7,534 | $1.28 |
| Jan 20, 2026 | Lily Cheung | Sale | 7,534 | $1.28 |
| Jan 20, 2026 | Bernard Coulie | Sale | 89,375 | $1.28 |
| Jan 20, 2026 | Bernard Coulie | Sale | 89,375 | $1.28 |
| Jan 20, 2026 | Bernard Coulie | Sale | 89,375 | $1.28 |
PLRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-149.34M | -2.43 | $-128.34M |
| Dec 31, 2024 | $0 | $-210.30M | -3.47 | $-155.50M |
| Dec 31, 2023 | $1.58M | $-161.34M | -2.75 | $-116.36M |
| Dec 31, 2022 | $9.69M | $-123.32M | -2.94 | $-94.63M |
| Dec 31, 2021 | $7.57M | $-97.26M | -2.71 | $-75.44M |
Latest balance sheet: total assets $189.88M, total liabilities $42.95M, cash $24.88M (as of Jun 30, 2026).
PLRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $1.03 |
| May 11, 2026 | 8-K Item 2.02 (results) | $1.20 |
| Mar 11, 2026 | 8-K Item 2.02 (results) | $1.33 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $1.53 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.46 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $1.38 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $15.19 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PLRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.